FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileHeartSciences Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
HSCSW
HeartSciences Inc. Stock AnalysisComprehensive stock analysis for HeartSciences Inc. (HSCSW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisHSCSW
HSCSW
HeartSciences Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
HSCSW
  1. Home
  2. Stocks
  3. HeartSciences Inc.

HeartSciences Inc.

🇺🇸HSCSW•NASDAQ

HeartSciences Inc.

🇺🇸HSCSW•NASDAQ
Market cap
$133.18K

Your view on HSCSW

Mkt Cap
$133.18K
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About HeartSciences Inc.

Industry
Medical - Devices
Sector
Healthcare
CEO
Andrew Simpson
Headquarters
550 Reserve Street, Southlake, TX, US
Industry
Medical - Devices
Sector
Healthcare
CEO
Andrew Simpson
Headquarters
550 Reserve Street, Southlake, TX, US
Description

Heart Test Laboratories, Inc. is a medical technology enterprise dedicated to the creation of diagnostic instruments for cardiovascular health. The company's primary offering is the MyoVista wavECG, a sophisticated 12-lead resting electrocardiograph.

This device provides essential diagnostic insights into cardiac dysfunction, in addition to supplying standard 12-lead resting ECG information. Serving a diverse range of medical environments, its products are adopted by clinics, physicians' offices, urgent care centers, and hospitals.

Founded in 2007, the firm's operations are headquartered in Southlake, Texas.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for HeartSciences Inc.. Starting points for HeartSciences Inc.: EPS -$2.80, beta 1.86 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for HeartSciences Inc.. Trailing twelve-month EPS for HeartSciences Inc. stands at -$2.80. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
More →

Earnings per share estimates

Per shareThis quarterJul 2022Next quarterJan 2023This yearYear to Dec 2025Next yearYear to Dec 2026
Average estimate−$28.00−$16.00−$3.47−$2.46
Lowest estimate−$28.00−$16.00−$3.47−$2.46
Highest estimate−$28.00−$16.00−$3.47−$2.46
Number of analysts1111
A year ago——−$9.34—
Growth vs a year ago——+62.8%—

Revenue estimates

TotalThis quarterJul 2022Next quarterJan 2023This yearYear to Dec 2025Next yearYear to Dec 2026
Average estimate$3000.00$1000.00$50000.00$17100.00
Lowest estimate$3000.00$1000.00$50000.00$17100.00
Highest estimate$3000.00$1000.00$50000.00$17100.00
Number of analysts1111
A year ago——$4350.00—
Growth vs a year ago——+1049.4%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for HeartSciences Inc.. HeartSciences Inc. has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold HSCSW19 companies
Compare HSCSW with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
BBLGBone Biologics CorporationHealthcareBiotechnology$909,962
BJDXBluejay Diagnostics, Inc.HealthcareMedical - Devices$1.9M
DHAIDIH Holding US, Inc.HealthcareMedical - Devices—
GCTKGlucoTrack, Inc.HealthcareMedical - Devices$179,582
MOVEMovano Inc.HealthcareMedical - Devices$103.2M
NDRAENDRA Life Sciences Inc.HealthcareMedical - Diagnostics & Research$5.4M
SHPHShuttle Pharmaceuticals Holdings, Inc.HealthcareDrug Manufacturers - Specialty & Generic$16.6M
More Medical - Devices companies
TickerTypeCompanySectorExchangeMkt cap
PXMBFPaxman AB (publ)HealthcareOTC$149.9M
PYNKFPerimeter Medical Imaging AI, Inc.HealthcareOTC$22.3M
QSIQuantum-Si incorporatedHealthcareNASDAQ$181.6M
QTIQT Imaging Holdings, Inc.HealthcareNASDAQ$28.2M
QTRXQuanterix CorporationHealthcareNASDAQ$93.1M
RBOTVicarious Surgical Inc.HealthcareNYSE$17.7M
RCELAVITA Medical, Inc.HealthcareNASDAQ$388.0M
RDGLVivos Inc.HealthcareOTC$38.5M
RMSLREMSleep Holdings, Inc.HealthcareOTC$9.5M
RPIDRapid Micro Biosystems, Inc.HealthcareNASDAQ$33.6M
RTGNRetinalGenix Technologies Inc.HealthcareOTC$59.5M
RXSTRxSight, Inc.HealthcareNASDAQ$187.4M
Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold HeartSciences Inc., and how their positions are changing. At a $133,180 market value, institutional positions materially move HeartSciences Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by HeartSciences Inc. executives and directors. Shares of HeartSciences Inc. have traded between $0.04 and $0.07 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for HeartSciences Inc.. Coverage tracks HeartSciences Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of HeartSciences Inc.

HSCSW AnalysisWeak
Past
1
Growth
1
Health
1
Profit
1
Value
1